Related references
Note: Only part of the references are listed.Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome A Randomized Clinical Trial
Yoon-Sim Yap et al.
JAMA ONCOLOGY (2017)
Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group
Ralf-Dieter Hofheinz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS
Dan Rosmarin et al.
GUT (2015)
On the identification of potential regulatory variants within genome wide association candidate SNP sets
Chih-yu Chen et al.
BMC MEDICAL GENOMICS (2014)
Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis
Dan Rosmarin et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy
Tareq Braik et al.
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY (2014)
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity
A. Loganayagam et al.
BRITISH JOURNAL OF CANCER (2013)
CTCF and Cohesin: Linking Gene Regulatory Elements with Their Targets
Matthias Merkenschlager et al.
CELL (2013)
MTHFR polymorphisms and capecitabine-induced toxicity in patients with metastatic colorectal cancer
Lieke H. van Huis-Tanja et al.
PHARMACOGENETICS AND GENOMICS (2013)
Genome-wide studies in pharmacogenomics: harnessing the power of extreme phenotypes
David Gurwitz et al.
PHARMACOGENOMICS (2013)
HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants
Lucas D. Ward et al.
NUCLEIC ACIDS RESEARCH (2012)
A Polymorphism in the Cytidine Deaminase Promoter Predicts Severe Capecitabine-Induced Hand-Foot Syndrome
Daniela Caronia et al.
CLINICAL CANCER RESEARCH (2011)
Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer
Maarten J. Deenen et al.
CLINICAL CANCER RESEARCH (2011)
Capecitabine and hand-foot syndrome
Muhammad Wasif Saif
EXPERT OPINION ON DRUG SAFETY (2011)
Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis
Cory L. Simpson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
A User's Guide to the Encyclopedia of DNA Elements (ENCODE)
Richard M. Myers et al.
PLOS BIOLOGY (2011)
Safety of capecitabine: a review
Sameh E. Mikhail et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid-Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5
Sherry L. Wolf et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Candidate mechanisms for capecitabine-related hand-foot syndrome
Gerard Milano et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progression
N. Ribelles et al.
CURRENT DRUG METABOLISM (2008)
Potential regional differences for the tolerability profiles of fluoropyrimidines
Daniel G. Haller et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier
Lisa M. Sevilla et al.
JOURNAL OF CELL BIOLOGY (2007)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
A Bayesian measure of the probability of false discovery in genetic epidemiology studies
Jon Wakefield
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Capecitabine: effective oral fluoropyrimidine chemotherapy
J McKendrick et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
The cornified envelope: A model of cell death in the skin
E Candi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
First-line oral capecitabine therapy in metastatic colorectal cancer:: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
J Cassidy et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
